Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease

Mesalazine is widely used in the treatment of inflammatory bowel disease. Little is known about the doseresponse relationship and about possible dose related side effects. In ulcerative colitis higher dosages of mesalazine (3 g) are more effective in maintaining a remission than lower dosages (1.5 g...

Full description

Saved in:
Bibliographic Details
Main Authors: C. J. J. Mulder (Author), S. J. Van Den Hazel (Author)
Format: Book
Published: Hindawi Limited, 1998-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available